ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Premium IconPremium Help Menu
S&P 500
5,980.87
-0.03%
US Tech 100
21,158.40
-0.02%
Dow Jones
42,171.66
-0.10%
Brent Oil
75.675
0.79%
Bitcoin
105,047.40
0.13%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Zymeworks Inc (ZYME) Quote

Zymeworks Inc

Zymeworks Inc (ZYME)

NASDAQ
12.63
0.39
(3.19%)
Closed June 19 4:00PM
15 min delayed - Upgrade to Realtime
12.63
0.01
(0.08%)
After Hours: 6:37PM
15 min delayed - Upgrade to Realtime

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
12.63
Bid
11.45
Ask
12.77
Volume
526,375
12.11 Day's Range 12.65
8.21 52 Week Range 17.70
Market Cap
880.103M
Previous Close
12.24
Open
12.25
Last Trade
51700
@
12.63
(priorref)
Last Trade Time
Financial Volume
$ 6,592,158
VWAP
12.5237
Average Volume (3m)
571,970
Shares Outstanding
69,683,492
Dividend Yield
-
PE Ratio
-7.17
Earnings Per Share (EPS)
-1.76
Revenue
76.3M
Net Profit
-122.7M

About Zymeworks Inc

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enable precise engineering of differentiat... Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enable precise engineering of differentiated product candidates. Its lead clinical candidate, zanidatamab, is a novel Azymetric HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.zymeworks.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Zymeworks Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ZYME. The last closing price for Zymeworks was $12.24. Over the last year, Zymeworks shares have traded in a share price range of $ 8.21 to $ 17.70.

Zymeworks currently has 69,683,492 shares outstanding. The market capitalization of Zymeworks is $852.93 million. Zymeworks has a price to earnings ratio (PE ratio) of -7.17.

Ask ADVFN Intelligence (AI)

ZYME Latest News

More News

Form 8-K - Current report
Edgar (US Regulatory)
May 30 2025
ZYME (3.19%)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Edgar (US Regulatory)
May 08 2025
ZYME (3.19%)

Form 8-K - Current report
Edgar (US Regulatory)
May 08 2025
ZYME (3.19%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.56-4.2456406368513.1913.43512.1239203112.70139534CS
40.352.8501628664512.2813.43511.0241713012.12606913CS
12-0.12-0.94117647058812.7513.4359.0357197011.55427227CS
26-0.68-5.1089406461313.3116.50659.0355274112.5170773CS
524.1348.58823529418.517.78.2157765212.19170844CS
1566.2597.96238244516.3817.76.01560737810.08226202CS
2606.2597.96238244516.3817.76.01560737810.08226202CS

ZYME - Frequently Asked Questions (FAQ)

What is the current Zymeworks share price?
The current share price of Zymeworks is $ 12.63
How many Zymeworks shares are in issue?
Zymeworks has 69,683,492 shares in issue
What is the market cap of Zymeworks?
The market capitalisation of Zymeworks is USD 852.93M
What is the 1 year trading range for Zymeworks share price?
Zymeworks has traded in the range of $ 8.21 to $ 17.70 during the past year
What is the PE ratio of Zymeworks?
The price to earnings ratio of Zymeworks is -7.17
What is the cash to sales ratio of Zymeworks?
The cash to sales ratio of Zymeworks is 11.53
What is the reporting currency for Zymeworks?
Zymeworks reports financial results in USD
What is the latest annual turnover for Zymeworks?
The latest annual turnover of Zymeworks is USD 76.3M
What is the latest annual profit for Zymeworks?
The latest annual profit of Zymeworks is USD -122.7M
What is the registered address of Zymeworks?
The registered address for Zymeworks is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Zymeworks website address?
The website address for Zymeworks is www.zymeworks.com
Which industry sector does Zymeworks operate in?
Zymeworks operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NWGLNature Wood Group Ltd
$ 5.615
(142.03%)
5.98M
KWEKWESST Micro Systems Inc
$ 11.2296
(94.96%)
37.36M
PTLEPTL Ltd
$ 0.3656
(84.74%)
404.15M
APVOAptevo Therapeutics Inc
$ 5.01
(77.66%)
124.46M
MRINMarin Software Incorporated
$ 1.435
(68.82%)
50.06M
CBIOCrescent Biopharma Inc
$ 14.60
(-71.45%)
97.59k
CEROCERo Therapeutics Holdings Inc
$ 11.5501
(-41.75%)
3.03M
BMEABiomea Fusion Inc
$ 1.90
(-34.48%)
11.66M
PSTVPlus Therapeutics Inc
$ 0.2025
(-34.38%)
23.9M
CONIGraniteShares ETF Trust 2X Short COIN Daily ETF
$ 3.7198
(-32.49%)
21.46M
HCTIHealthcare Triangle Inc
$ 0.0265
(19.91%)
455.2M
PTLEPTL Ltd
$ 0.3656
(84.74%)
404.15M
GNLNGreenlane Holdings Inc
$ 0.01035
(-0.48%)
260.94M
NVDANVIDIA Corporation
$ 145.48
(0.94%)
161.49M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
$ 12.365
(3.56%)
141.16M

Discussion

View Full Feed
Seminole Red Seminole Red 4 minutes ago
Amen
Juntao Juntao 4 minutes ago
https://www.otcmarkets.com/stock/ECGI/security still no change.
ECGI
dennisdave dennisdave 4 minutes ago
I think the biggest month to look for is July for reasons I have discussed here at length a few times now and not June.
NWBO
Methinks Methinks 8 minutes ago
https://www.theactuary.com/news/2025/06/19/significant-cyberattacks-canada-set-triple-two-years
This is why Wave is so important.
dennisdave dennisdave 8 minutes ago
f the MHRA wants to reject, they must first refer it to a CHM meeting for review. Once that happens, and the CHM backs the MHRA's recommendation to reject, NWBO is then allowed to go through an appeal process which can take months if not years.

You are partially misstating this.
HMR NWBO
Methinks Methinks 9 minutes ago
https://www.techradar.com/pro/security/scania-hit-by-cyberattack-thousands-of-customers-potentially-affected-heres-what-we-know
This is just too common. ACT NOW WITH WAVE.
Methinks Methinks 10 minutes ago
https://www.darkreading.com/threat-intelligence/iran-israel-war-maelstrom-cyberspace
ACT NOW WITH WAVE.
tycoon7 tycoon7 18 minutes ago
Is there any information coming from the Underhill's about Hellix stock?
HLLXF
bigfart bigfart 21 minutes ago
https://www.independent.co.uk/news/world/americas/tesla-cybertruck-lawsuit-driver-burned-bones-disintegrated-b2771728.html
TSLA
SupernovaGolem92 SupernovaGolem92 21 minutes ago
Let’s be realistic: a Tier 1 contract with Nvidia or TSMC in 2025 or 2026 is extremely unlikely. Startups often mention “Tier 1 contacts” to attract investors — usually this just means a meeting or early-stage evaluation, not a signed agreement or revenue. Companies like Nvidia only partner once a t
LWLG
pinkslipjunkie pinkslipjunkie 23 minutes ago
INGO BINGO on that!
Anyone not owning shares and posting here should be the least of the worries. Look no further than the sp
ASII
Bull_Dolphin Bull_Dolphin 26 minutes ago
May Justice Thomas live a long life and continue to serve:

In Landmark Skrmetti Case, Justice Thomas Demolishes The ‘Expert Class’
By: Shawn Fleetwood
June 18, 2025
https://thefederalist.com/wp-content/uploads/2025/06/Clarence-Thomas.png
Clarence Thomas giv
bigfart bigfart 29 minutes ago
Drive a Tesla to the barbecue....... 250 coming boys
TSLA
diamondguru-one diamondguru-one 31 minutes ago
Baaaaaaaaaaaaaaam !!!!!!!!!! Gooooooooo RD
COOP
sctts sctts 32 minutes ago
$$$ Today is the Day $$$$

$$$SFRX$$$
SFRX
breynolds breynolds 35 minutes ago
Tomorrow is going to be wild!!!
🤪 
GTCH
Hi_Lo Hi_Lo 36 minutes ago
No FINRA issue here. Sharp answers a few questions for FINRA.
Is this just more of your many lies which others and I constantly call you out on?

Funny, even Sharp said that GVSI has FINRA issues.

https://twitter.com/OTCpinkGVSI/status/1729558323119202449?t=AMKXpV
GVSI HMBL
Ranb2khz Ranb2khz 37 minutes ago
FAKE MINECRAFT MODS DISTRIBUTED BY THE STARGAZERS GHOST NETWORK TO STEAL GAMERS’ DATA

~ by Jaromír Horejší (@JaromirHorejsi), Antonis Terefos (@Tera0017), June 18, 2025

Key Points

• Check Point Research discovered a multistage campaign targeting Minecraft
Bob Mullet Bob Mullet 44 minutes ago
Must've been buffet. No one else could swing that 2k mega deal 
KBLB
shajandr shajandr 44 minutes ago
[yt]SYGYGbkXnRs[/yt]
[yt]ZZvx3q21d8s[/yt]
[yt]3Nl11tSz4OE[/yt]
BA
Ranb2khz Ranb2khz 46 minutes ago
What’s Trending: Top Cyber Attacker Techniques, March–May 2025

~ by Reliaquest Threat Research Team, 18 June 2025

Key Points

• “ClickFix” tactics have fueled the surge in malware like “Lumma” and “SectopRAT,” using trusted tools like MSHTA to bypass defen
Edward Edward 54 minutes ago
I done with iHub nothing but BS here anyways! Goodbye!!!

Everyone knows this isn't true. He has never told the truth on the VXIT board.

I will be proven right.

Might not be this week, but we will see more posts from him on the VXIT board.
VXIT
snow snow 54 minutes ago
Were the quarterly numbers good?I think they were at least very confusing. My impression is that stocktwits suggests that earnings per share were expected to be 19 cents and revenue 25 million dollars. Revenues were less than 18 million dollars. Earnings per share seem to have been either 23 cents p
GRRR
Preciouslife1 Preciouslife1 55 minutes ago
https://news.bitcoin.com/ripple-and-sec-press-judge-torres-to-approve-settlement-ending-xrp-case/
XRPUSD
vareddi vareddi 1 hour ago
my account with Lehman says 120.xxx,xx
LEHNQ

Your Recent History

NASDAQ
ZYME
Zymeworks
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub
United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN Ltd - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads